Ironwood Pharmaceuticals Files 8-K on Financials
Ticker: IRWD · Form: 8-K · Filed: Apr 25, 2025 · CIK: 1446847
| Field | Detail |
|---|---|
| Company | Ironwood Pharmaceuticals Inc (IRWD) |
| Form Type | 8-K |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
TL;DR
Ironwood Pharma dropped an 8-K on financials - check it for the latest numbers.
AI Summary
On April 25, 2025, Ironwood Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were provided in the excerpt.
Why It Matters
This filing indicates Ironwood Pharmaceuticals is providing updates on its financial performance and condition to the SEC, which is crucial for investors to assess the company's health.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting routine financial information, not indicating any immediate or unusual risks.
Key Players & Entities
- IRONWOOD PHARMACEUTICALS, INC. (company) — Registrant
- April 25, 2025 (date) — Date of Report
- 001-34620 (company) — Commission File Number
- 04-3404176 (company) — I.R.S. Employer Identification Number
- 100 Summer Street, Suite 2300 (location) — Principal Executive Offices Address
- Boston, Massachusetts (location) — Principal Executive Offices City/State
- 02110 (location) — Principal Executive Offices Zip Code
- 617-621-7722 (phone) — Registrant's telephone number
FAQ
What specific financial results are being reported by Ironwood Pharmaceuticals in this 8-K?
The provided excerpt states the 8-K concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail the specific financial figures.
When was this 8-K report filed with the SEC?
The report was filed on April 25, 2025.
What is Ironwood Pharmaceuticals' primary business according to the SIC code?
The Standard Industrial Classification (SIC) code provided is [2834], which corresponds to 'PHARMACEUTICAL PREPARATIONS'.
Where is Ironwood Pharmaceuticals, Inc. headquartered?
The company's principal executive offices are located at 100 Summer Street, Suite 2300, Boston, Massachusetts 02110.
What is the Commission File Number for Ironwood Pharmaceuticals?
The Commission File Number for Ironwood Pharmaceuticals, Inc. is 001-34620.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 25, 2025 regarding IRONWOOD PHARMACEUTICALS INC (IRWD).